The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Early mortality (EM) for newly diagnosed multiple myeloma (NDMM) in the Connect MM U.S. registry.
Howard R. Terebelo
Consultant or Advisory Role - Celgene
Honoraria - Celgene
Jatin J. Shah
Consultant or Advisory Role - Array BioPharma; Celgene; Novartis; Onyx
Research Funding - Array BioPharma; Bristol-Myers Squibb; Celgene; Millennium; Novartis; Onyx
Brian G. Durie
Consultant or Advisory Role - Amgen (U)
Rafat Abonour
Consultant or Advisory Role - Celgene
Honoraria - Celgene; Onyx
Cristina Gasparetto
Consultant or Advisory Role - Celgene
Honoraria - Celgene; Millennium
Other Remuneration - Novartis (I)
Jayesh Mehta
Consultant or Advisory Role - Celgene
Honoraria - Celgene (B); Millennium (B); Takeda (B)
Mohit Narang
Consultant or Advisory Role - Celgene
Sachdev P. Thomas
Consultant or Advisory Role - Celgene
Honoraria - Celgene
Kathleen Toomey
Consultant or Advisory Role - Celgene
Chris L. Pashos
Consultant or Advisory Role - Celgene
Research Funding - Celgene
Arlene S. Swern
Employment or Leadership Position - Celgene
Stock Ownership - Celgene
Kristen A. Sullivan
Employment or Leadership Position - Celgene
Stock Ownership - Celgene
Thomas K. Street
Employment or Leadership Position - Celgene
Stock Ownership - Celgene
Shankar Srinivasan
Employment or Leadership Position - Celgene
Stock Ownership - Celgene
Ali Nourbakhsh
Employment or Leadership Position - Celgene
Stock Ownership - Celgene
James W. Hardin
No relevant relationships to disclose
Robert M. Rifkin
Consultant or Advisory Role - Celgene; Millennium; Onyx; Takeda
Honoraria - Celgene; Millennium; Onyx; Takeda